Newsletter BOX: Before the Bell: Stock futures imply sharp drop at open, government shutdown looms

09/30/2013

Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between

Stock futures imply sharp drop at open, government shutdown looms

NEW YORK (Reuters) - U.S. stock index futures pointed to a sharply lower open on Monday as a last-minute deal to resolve a budget battle in Washington appeared less likely, increasing the chances of a partial government shutdown.

OZ Minerals says received no bid from Glencore

MELBOURNE (Reuters) - OZ Minerals Ltd said on Monday it had not been approached by Glencore Xstrata with any offer, dismissing a British newspaper report that said Glencore was weighing a 750 million pound ($1.2 billion) bid for the Australian copper miner.

Wall Street banks likely stung again by bad bond-trading quarter

NEW YORK (Reuters) - Wall Street banks have had another rough quarter in bond trading thanks to the U.S. Federal Reserve, and it might get worse before it gets better.

Siemens' new CEO riles labor reps with news of job cuts

MUNICH/FRANKFURT (Reuters) - Weekend news of 15,000 job cuts at Germany's Siemens has put the German engineering group's new chief executive, Joe Kaeser, on a collision course with workers' representatives only two months after he took the helm.

BMW, Hyundai and Kia recall over 180,000 cars in China

BEIJING (Reuters) - BMW , Hyundai Motor Co and Hyundai's affiliate Kia Motors Corp are recalling a total of 181,492 cars in China, the country's quality watchdog said on Friday.

GSK sells thrombosis drugs to Aspen for $1 billion

LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline agreed the 700 million pounds ($1.13 billion) sale of its thrombosis drug brands and a related factory to Aspen Pharmacare , as part of its strategy to focus on growth products.

AstraZeneca CEO gets two cheers after first year in job

LONDON (Reuters) - Fixing ailing drugmaker AstraZeneca remains a work in progress for Chief Executive Pascal Soriot, with sales and profits still heading firmly downhill after his first year in the job.

Rosneft offers lowball $1.5 billion for TNK-BP minorities

MOSCOW (Reuters) - Oil group Rosneft is to buy the remaining shares in TNK-BP Holding for a fraction of the price it paid BP and a group of oligarchs for their stakes, in a worrying development for minority shareholders in Russian companies.

Investors cut U.S. stocks, bonds on policy uncertainty

LONDON (Reuters) - Global investors cut allocation to U.S. equities and bonds this month as uncertainty about U.S. monetary and fiscal policies grew, a Reuters poll showed on Monday.

Pharma industry should support China curbs on corruption: Sanofi CEO

MUMBAI (Reuters) - The pharmaceutical industry should support the Chinese government's efforts to curb corruption, French drugmaker Sanofi's Chief Executive Chris Viehbacher said on Monday.